Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on WW International (WW – Research Report), Rush Street Interactive (RSI – Research Report) and Nike (NKE – Research Report).
WW International (WW)
In a report released today, Alex Fuhrman from Craig-Hallum maintained a Hold rating on WW International. The company’s shares closed last Wednesday at $4.60, close to its 52-week low of $3.46.
According to TipRanks.com, Fuhrman has 0 stars on 0-5 stars ranking scale with an average return of
WW International has an analyst consensus of Moderate Buy, with a price target consensus of $11.67.
See the top stocks recommended by analysts >>
Rush Street Interactive (RSI)
In a report released today, Ryan Sigdahl from Craig-Hallum maintained a Hold rating on Rush Street Interactive, with a price target of $6.00. The company’s shares closed last Wednesday at $5.55, close to its 52-week high of $5.65.
According to TipRanks.com, Sigdahl is a 5-star analyst with an average return of
Currently, the analyst consensus on Rush Street Interactive is a Moderate Buy with an average price target of $6.00.
Nike (NKE)
In a report released today, Cristina Fernandez from Telsey Advisory maintained a Buy rating on Nike, with a price target of $140.00. The company’s shares closed last Wednesday at $103.79.
According to TipRanks.com, Fernandez is a 4-star analyst with an average return of
Currently, the analyst consensus on Nike is a Moderate Buy with an average price target of $124.43, representing a 21.5% upside. In a report issued on January 29, UBS also maintained a Buy rating on the stock with a $138.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on WW:
- Labcorp Elevates Employee Health Benefits with WeightWatchers for Business Full-Spectrum Weight Health Platform
- Labcorp elevates employee health benefits with WeightWatchers
- WW downgraded to Buy from Conviction Buy at Goldman Sachs
- GLP-1 Anti-Obesity Drugs: Slim Waistlines, Fat Profits
- WW recent selloff ‘disconnected’ with alternative data, says Morgan Stanley
